申请人:Haeberlein Markus
公开号:US20060178372A1
公开(公告)日:2006-08-10
Provided herein is a compound having the formula (I):
Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT
1B
and 5HT
1D
antagonists.
本文提供的化合物具有公式(I):其中所述的化合物可用于治疗精神障碍,包括但不限于抑郁症,广泛性焦虑症,进食障碍,痴呆症,惊恐障碍和睡眠障碍。该化合物还可以用于治疗胃肠道疾病,心血管调节,运动障碍,内分泌障碍,血管痉挛和性功能障碍。该化合物是5HT1B和5HT1D拮抗剂。